Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors

Cancer Research

Volumn 58, Issue 12, 1998, Pages 2652-2660

  Luo, Jin Cai ^a   Yamaguchi, Sachiko ^a   Shinkai, Akeo ^b   Shitara, Kenya ^b   Shibuya, Masabumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES FLUID; ASCITES TUMOR; BLOOD VESSEL WALL; CONTROLLED STUDY; HISTOLOGY; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ASCITES; ASCITIC FLUID; ENDOTHELIAL GROWTH FACTORS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; NEOPLASM PROTEINS; PERITONEAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0005419856     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146: 1029-1039, 1995.
2. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. The human gene for vascular endothelial growth factor. J. Biol. Chem., 266: 11947-11954, 1991.
3. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC), 219: 983-985, 1983.
4. Ferrara, N., and Henzel, W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 161: 851-858, 1989.
5. Shibuya, M. Role of VEGF-Flt receptor system in normal and tumor angiogenesis. Adv. Cancer Res., 281-316: 1995.
6. Alon, T., Hemo, I., Itin, A., Péer, J., Stone, J., and Keshet, E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med., 1: 1024-1028, 1995.
7. Shima, D. T., Kuroki, M., Deutsch, U., Ng, Y. S., Adamis, A. P., and D'Amore, P. A. The mouse gene for vascular endothelial growth factor. J. Biol. Chem., 271: 3877-3883, 1996.
8. Georg, B., Albrecht, U., Sterrer, S., and Risau, W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation Development (Camb.), 114: 521-532, 1992.
9. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Washington DC), 246: 1306-1309, 1989.
10. Bacic, M., Edwards, N. A., and Merrill, M. J. Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors, 12: 11-15, 1995.
11. Kieser, A., Weich, H., Bandner, G., Marme, D., and Kolch, W. Mutant p53 potentiates protein kinase C induction of vascular growth factor expression. Oncogene, 9: 963-969, 1994.
12. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes up-regulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
13. Mukhopadhyay, D., Tsiokas, L., and Sukhatme, V. P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression Cancer Res., 55: 6161-6165, 1995.
14. Ferrara, N., and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev., 18: 4-25, 1997.
15. Goldberg, M. A., and Schneider, T. J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem., 269: 4355-4361, 1994.
16. Berse, B., Brown, L. F., Water, L. V. D., Dvorak, H. F., and Senger, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell., 3: 211-220, 1992.
17. Yeo, K. T., Wang, H. H., Nagy, J. A., Scioussat, T. M., Ledbetter, S. R., Hoogewerf, A. J., Zhou, Y., Masse, E. M., Senger, D. R., Dvorak, H. F. and Yeo, T. K. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res., 53: 2912-2918, 1993.
18. Nagy, J. A., Masse, E. M., Herzberg, K. T., Meyers, M. S., Yeo, K. T., Yeo, T. K., Siossat, and Dvorak, H. F. Pathogenesis of ascites tumor growth: vascular permeability factor vascular hyperpermeability, and ascites fluid accumulation. Cancer Res., 55: 360-368, 1995.
19. Lewin, F., Ringborg, U., Skop, S., and Tribukait, B. The effect of 5-fluorouracil on cisplatin induced DNA interstrand cross-linking in a mouse ascites tumor growing in vivo. Anticancer Drugs, 6: 465-470, 1995.
20. Takeuchi, S., Irie, R. F., Inoue, M., Irie, K., Izumi, R., and Nishioka, K. Immunological studies on mouse mammary tumors. II. Characterization of tumor-specific antibodies against mouse mammary tumors. Int. J. Cancer, 4: 130-138, 1969.
21. Kamisaki, Y., Wada, H., Yagura, T., Nishimura, H., Matsushima, A., and Inada, Y. Increased antitumor activity of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol. Gann, 73: 470-474, 1982.
22. Yamamoto, T., and Takeuchi, M. Studies on Rous sarcoma virus in mice. I. establishment of an ascites sarcoma induced by Schmidt-Ruppin strain of Rous sarcoma virus in C3H/He mouse. Jpn. J. Exp. Med., 37: 37-50, 1967.
23. Yotoku, M., and Kitagawa, M. The role of alloantibodies on in vivo growth of allografted tumor. Transplant. Proc., 7: 961-964, 1975.
24. Nakayoshi, H., and Watanabe, T. Suppression of sarcoma 37 in mice by the treatment with extracellular polysaccharide produced by a strain of Crepidotus sp. Jpn. J. Exp. Med. 38: 437-442, 1968.
25. Takeuchi, M., Hino, S., and Yamamoto, T. Studies on Rous sarcoma virus in mice. III. Three lines of SR-SRV-induced mouse ascites sarcomas. Jpn. J. Exp. Med., 39: 239-251, 1969.
26. Egawa, K. Choi, Y. S., and Tanino, T. Growth development changes of glycolipid compositions of mouse ascites tumor cells. Jpn. J. Exp. Med., 45: 155-159, 1975.
27. Furuno, T., Teshima, R., Kitani, S., Sawada, J., and Nakanishi, M. Surface expression of CD36 antigen (AD1 antigen) in P815 mastocytoma cells by transfected IgE receptors. Biochem. Biophys. Res. Commun., 219: 740-744, 1996.
28. Liu, F-T., Zinnecker, M., Hamaoka, T., and Katz, D. H. New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry, 18: 690-697, 1979.
29. Tanaka, K., Yamaguchi, S., Sawano, A., and Shibuya, M. Characterization of the extracellular domain in the vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase). Jpn. J. Cancer Res., 88: 867-876, 1997.
30. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., and Shibuya, M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene, 10: 135-147, 1995.
31. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2, pp. 18.60-18.74. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
32. Yamane, A., Seetharam, L., Yamaguchi, S., Gotoh, N., Takahashi, T., Neufeld G., and Shibuya, M. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene, 9: 2683-2690, 1994.
33. Miles, A. A., and Miles, E. M. Vascular reactions to histamine, histamine liberators or leukotoxins in the skin of the guinea pigs. J. Physiol., 118-257, 1952.
34. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2, pp. 7.6-7.52. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
35. Berm, S., Cotran, S. S., and Folkman, J. Tumor angiogenesis: a quantitative method for histological grading. J. Natl. Cancer Inst., 48: 347-356, 1972.
36. Luo, J. C., Toyoda, M., Shibuya, M. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody Cancer Res., 58: 2594-2600, 1998.
37. Probst, Hans., Schiffer, H., Gekeler, V., Kienzle-Pfeilsticker, H., Stropp, U., Stötzer, K-E., and Frenzel-Stötzer, I. Oxygen dependent regulation of DNA synthesis and growth of Ehrlich ascites tumor cells in vitro and vivo. Cancer Res., 48: 2053-2060, 1988.
38. Fiebich, B., Jäger, B., Schöllmann, C., Weindel, K., Wilting, J., Kochs, G., Marmé, D., Hug, H., and Weich, H. A. Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Eur. J. Biochem., 211: 19-26, 1993.
39. Dvorak, H. F., Scioussat, T. M., Brown, L. F., Berse, B., Nagy, J. A., Sotrel, A., Manseau, E. J., Water, L. V. D., and Senger, D. R. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med., 174: 1275-1278, 1991.
40. Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. T., Jamoel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., Nguyen, H. V., Aiello, L. M., Ferrara, N., and King, G. L. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal diseases. N. Engl. J. Med., 331: 1480-1487, 1994.
41. Fava, R. A., Olsen, N. J., Spencer-Green, G., Yeo, K-T., Berse, B., Jackman, R. W., Senger, D. R., Dvorak, H. F., and Brown, L. F. Vascular permeability factor/ endothelial growth factor: accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med., 180: 341-346, 1994.
42. 189. Proc. Natl. Acad. Sci. USA, 94: 12081-12087, 1997.
43. Van De Brenk, H. A. S., Crowe, M., Kelly, H., and Stine, M. G. The significance of free blood in liquid and solid tumors. Br. J. Exp. Pathol., 58: 147-159, 1989.
44. Heuser, L. S., Taylor, S. H., and Folkman, J. Prevention of carcinomatosis and bloody ascites in the rat by an inhibitor of angiogenesis. J. Surg. Res., 36: 244-250, 1984.
45. Feldman, G. B., Knapp, R. C., Order, S. E., and Hellman, S. The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res., 32: 1663-1666, 1972.
46. 99mTc-sulfur colloid. Radiology. 107: 577-583, 1973.
47. Feldman, G. B., Knapp, R. C. Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer. Am. J. Obstet. Gynecol., 119: 991-994, 1974.
48. Hoffmann, J., Schimer, M., Menrad, A., and Schneider, M. R. A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells. Cancer Res., 57: 3847-3851, 1997.
49. Harris, J. W., Meyskens, F., and Patt, H. M. Biochemical studies of cytokinetic changes during tumor growth. Cancer Res., 30: 509-519, 1962.
50. Gekeler, V., Epple, J., Kleymann, and Probst, H. Selective and synchronous activation of early-S-phase replicons of Ehrlich ascites cells. Mol. Cell. Biol., 13: 5020-5033, 1993.
51. Rosenthal, R. S., Megyesi, J., Henzel, W. J., Ferrara, N., and Folkman, J. Conditioned medium from mouse Sarcoma 180 cells contains vascular endothelial growth factor. Growth Factors, 4: 53-59, 1990.
52. Dellian, M., Witwer, B. P., Salehi, H. A., Jain, R. K. Quantitation and physiological characterization of an angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am. J. Pathol., 149: 59-71, 1996.
53. Nagy, J. A., Morgan, E. S., Herzberg, K. T., Manseau, E. J., Dvorak, A. M., and Dvorak, H. F. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res., 55. 376-385, 1995.
54. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis Lung carcinoma. Cell, 79: 315-328, 1994.
55. Maeda, H., Noguchi, Y., Sato, K., and Akaike, T. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res., 85: 331-334, 1994.
56. Greenbaum, L. M., Grebow, P., Johnston, M., Prakash, A., and Semente, G. Pepstatin, an inhibitor of leukokinin formation and ascitic fluid accumulation. Cancer Res., 35: 706-710, 1975.